Company information:
Stirling Anglian Pharmaceuticals Limited (No: SC453258)
Address: HILLINGTON PARK INNOVATION CENTRE AINSLIE ROAD, HILLINGTON PARK, GLASGOW, G52 4RU
Status: Active
Incorporated: 26-Jun-2013
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 20-Jul-2024
Industry Class: 86900 - Other human health activities
Current Director: MARK CHARLES INKER ( DOB: Jun-1964 From: Feb-2023 )
Current Director: ANDREW FIRTH MCLEAN ( DOB: Aug-1965 From: Dec-2021 )
Current Director: HARRY THOMAS STRATFORD ( DOB: Nov-1970 From: Dec-2021 )
Current Director: ALLAN MARK WATSON ( DOB: Jan-1967 From: Dec-2021 )
Current Director: ALLAN MARK WATSON ( DOB: Jan-1967 From: Dec-2021 )
Resigned Director: MATTHEW ROBERT ALSOP ( DOB: May-1971 From: Oct-2013 To: Oct-2016 )
Resigned Director: MARK COOK ( DOB: Feb-1966 From: Oct-2013 To: Dec-2021 )
Resigned Director: CAROL ANN FARQUHARSON ( DOB: Sep-1961 From: Jan-2014 To: Jan-2017 )
Resigned Director: PHILIP MCMENEMY ( From: Oct-2013 To: Sep-2016 )
Resigned Director: GERHARD WILHELM NEUMAIER ( From: Jul-2014 To: Jul-2017 )
Resigned Director: SEAN AMBROSE PERRIE ( DOB: Apr-1992 From: Jun-2013 To: Dec-2021 )
Resigned Director: STEPHEN PETER SCULLION ( From: Feb-2015 To: Oct-2016 )
Resigned Director: ALASTAIR THORBURN ( From: Oct-2013 To: Dec-2014 )
Resigned Director: KAREN MARY WESTAWAY ( DOB: Jan-1958 From: Oct-2013 To: Apr-2015 )
Persons of Significant Control:
Kelso International Limited, 17 Godliman Street, London, EC4V 5BD, England: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2021-12-21)
Mr Sean Ambrose Perrie, Hillington Park Innovation Centre Ainslie Road, Hillington Park, Glasgow, G52 4RU: Ownership of shares – More than 50% but less than 75% (Notified: 2016-04-06, Ceased: 2021-12-21)
Company Accounts Summary (£)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | Chart |
|---|---|---|---|---|---|---|---|
| Fixed assets | 287,779 | 186,034 | 145,613 | 73,128 | 89,577 | 16,799 | 287779.0,186034.0,145613.0,73128.0,89577.0,16799.0 |
| Fixed assets / Intangible assets | 279,772 | 181,956 | 145,289 | 73,089 | 87,290 | 14,502 | 279772.0,181956.0,145289.0,73089.0,87290.0,14502.0 |
| Fixed assets / Property, plant and equipment | 8,007 | 4,078 | 324 | 39 | 2,287 | 2,297 | 8007.0,4078.0,324.0,39.0,2287.0,2297.0 |
| Current assets | 2,042,451 | 2,506,179 | 2,287,812 | 2,569,548 | 3,933,013 | 4,271,353 | 2042451.0,2506179.0,2287812.0,2569548.0,3933013.0,4271353.0 |
| Current assets / Total inventories | 499,133 | 713,930 | 361,283 | 552,655 | 626,182 | 803,929 | 499133.0,713930.0,361283.0,552655.0,626182.0,803929.0 |
| Current assets / Debtors | 1,425,365 | 1,770,118 | 1,818,116 | 1,884,842 | 2,631,197 | 2,815,624 | 1425365.0,1770118.0,1818116.0,1884842.0,2631197.0,2815624.0 |
| Current assets / Cash at bank and on hand | 117,953 | 22,131 | 108,413 | 132,051 | 675,633 | 651,800 | 117953.0,22131.0,108413.0,132051.0,675633.0,651800.0 |
| Net current assets (liabilities) | -489,061 | -1,011,688 | -163,269 | 199,322 | 63,092 | 1,852,345 | -489061.0,-1011688.0,-163269.0,199322.0,63092.0,1852345.0 |
| Total assets less current liabilities | -201,282 | -825,654 | -17,656 | 272,450 | 152,669 | 1,869,144 | -201282.0,-825654.0,-17656.0,272450.0,152669.0,1869144.0 |
| Net assets (liabilities) | -2,403,335 | -2,829,173 | -1,663,275 | -1,117,674 | -730,228 | 879,976 | -2403335.0,-2829173.0,-1663275.0,-1117674.0,-730228.0,879976.0 |
| Equity / share capital and reserves | -2,403,335 | -2,829,173 | -1,663,275 | -1,117,674 | -730,228 | 879,976 | -2403335.0,-2829173.0,-1663275.0,-1117674.0,-730228.0,879976.0 |